Clinical Trials Browser

Phase 3 × Pancreatic Cancer Resectable × Irinotecan × Clear all

NCT07155629 2025-09-04

LEFT-PANC

Phase 3 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Resectable